Utah Medical Products (UTMD) announces that its board of directors has appointed Kevin C. Timken, Esq to its board. In addition, the board approved a quarterly cash dividend of 31c per share of common stock payable on January 5 to shareholders of record at the close of business on December 16. This is a 1.6% increase over the prior regular quarterly cash dividend.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UTMD: